Danaparoid and sepsis Patient Reports February 12, 2012

Danaparoid Side Effects Report #5065826-2
Danaparoid side effect was reported by a Health Professional from FRANCE on July 19, 2006. Female patient, 83 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, hepatic failure, sepsis , small intestine gangrene. Danaparoid dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, PANTOPRAZOLE, FUROSEMIDE. Patient died.

Danaparoid Side Effects Report #5139585-9
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Oct 17, 2006. Female patient, 69 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: arthritis bacterial, deep vein thrombosis , sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, ENOXAPARIN. Patient died.

Danaparoid Side Effects Report #5139581-1
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Oct 17, 2006. Female patient was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #5096633-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dehydration, hyperkalaemia, hypocholesterolaemia, leukocytosis, liver disorder, renal failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with CEFOZOPRAN HYDROCHLORIDE, VANCOMYCIN, BIAPENEM, TEICOPLANIN, MICAFUNGIN, PREDNISOLONE ACETATE, PROPOFOL. Patient died.


Danaparoid Side Effects Report #5110463-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5116971-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4568431-7
Danaparoid side effect was reported by a Consumer or non-health professional from on Jan 25, 2005. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, SOLDEM, PREDNISOLONE, FUROSEMIDE, RANITIDINE HYDROCHLORIDE, OMEPRAZOLE, HICALIQ, SOHVITA. Patient died.

Danaparoid Side Effects Report #5084714-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 09, 2006. Male patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cerebral haemorrhage, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFTAZIDIME, AMIKACIN SULPHATE, FLURBIPROFEN AXETIL, GLYCEOL, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5020447-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Male patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cerebral haemorrhage, haemoglobin decreased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE HDYROCHLORIDE, CEFTAZIDIME, AMIKACIN SULPHATE, FLUBIPROFEN AXETIL, GLYCEROL, CARBAZOCHROME, TRANEXAMIC ACID. Patient died.


Danaparoid Side Effects Report #5024837-3
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on June 01, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, sepsis , septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5020454-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Female patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased, protein total decreased, sepsis , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with SULPERAZON, FAMOTIDINE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, FLURBIPROFEN, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, ISEPAMICIN SULPHATE. Patient died.

Danaparoid Side Effects Report #4576350-5
Danaparoid side effect was reported by a Physician from on Feb 01, 2005. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, leukaemia, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE, CHLORPHENIRAMINE MALEATE, AMPHOTERICIN B, PANTHENOL, VITAJECT, ELEMENMIC, VANCOMYCIN HYDROCHLORIDE, POTASSIUM CHLORIDE. Patient died.

Danaparoid Side Effects Report #5024840-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, renal impairment, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5030494-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, renal impairment, sepsis , thermal burn. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.


Danaparoid Side Effects Report #5116965-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, CILASTATIN W, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5024833-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, TIENAM, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.